Ken Fisher Invitae Corp Transaction History

Fisher Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2023	BUY	$1.05 - $1.63 $185,882 - $288,560	177,031 New	177,031 $200,000
Q2 2023 Aug 08, 2023	SELL	$1.05 - $1.63 $105 - $163	-100 Reduced 0.06%	177,031 $200,000
Q1 2023 Dec 12, 2023	BUY	$1.2 - $2.73 $212,437 - $483,294	177,031 New	177,031 $238,000
Q1 2023 May 01, 2023	SELL	$1.2 - $2.73 $240 - $546	-200 Reduced 0.11%	177,131 $239,000
Q4 2022 Feb 03, 2023	SELL	$1.71 - $3.61 $4.93 Million - $10.4 Million	-2,884,007 Reduced 94.21%	177,331 $330,000
Q3 2022 Nov 08, 2022	SELL	$1.9 - $8.63 $80,351 - $364,962	-42,290 Reduced 1.36%	3,061,338 $7.53 Million
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $3.35 Million - $14.2 Million	1,570,834 Added 102.48%	3,103,628 $7.57 Million
Q1 2022 May 05, 2022	SELL	$6.28 - $15.59 $1,256 - $3,118	-200 Reduced 0.01%	1,532,794 $12.2 Million
Q4 2021 Feb 02, 2022	BUY	$14.7 - $28.67 $10.3 Million - $20 Million	699,048 Added 83.82%	1,532,994 $23.4 Million
Q3 2021 Oct 26, 2021	BUY	$24.31 - $33.6 $20.3 Million - $28 Million	833,946 New	833,946 $23.7 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.